MAP3K14

From Wikipedia, the free encyclopedia
Jump to: navigation, search
MAP3K14
Available structures
PDB Ortholog search: PDBe RCSB
Identifiers
Aliases MAP3K14, FTDCR1B, HS, HSNIK, NIK, mitogen-activated protein kinase kinase kinase 14
External IDs MGI: 1858204 HomoloGene: 2940 GeneCards: MAP3K14
RNA expression pattern
PBB GE MAP3K14 205192 at fs.png
More reference expression data
Orthologs
Species Human Mouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_003954

NM_016896

RefSeq (protein)

NP_003945

NP_058592

Location (UCSC) Chr 17: 45.26 – 45.32 Mb Chr 11: 103.22 – 103.27 Mb
PubMed search [1] [2]
Wikidata
View/Edit Human View/Edit Mouse

Mitogen-activated protein kinase kinase kinase 14 also known as NF-kappa-B-inducing kinase (NIK) is an enzyme that in humans is encoded by the MAP3K14 gene.[3][4]

Function[edit]

This gene encodes mitogen-activated protein kinase kinase kinase 14, NIK, which is a serine/threonine protein-kinase. This kinase binds to TRAF2 and stimulates NF-κB activity. It is a critical kinase of the alternative NF-κB activation pathway. It shares sequence similarity with several other MAPKK kinases. It participates in an NF-κB-inducing signalling cascade common to receptors of the tumour-necrosis/nerve-growth factor (TNF/NGF) family and to the interleukin-1 type-I receptor.[4]

Interactions[edit]

MAP3K14 has been shown to interact with:

References[edit]

  1. ^ "Human PubMed Reference:". 
  2. ^ "Mouse PubMed Reference:". 
  3. ^ a b Malinin NL, Boldin MP, Kovalenko AV, Wallach D (March 1997). "MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1". Nature. 385 (6616): 540–4. PMID 9020361. doi:10.1038/385540a0. 
  4. ^ a b "Entrez Gene: MAP3K14 mitogen-activated protein kinase kinase kinase 14". 
  5. ^ a b c Luftig MA, Cahir-McFarland E, Mosialos G, Kieff E (May 2001). "Effects of the NIK aly mutation on NF-kappaB activation by the Epstein-Barr virus latent infection membrane protein, lymphotoxin beta receptor, and CD40". J. Biol. Chem. 276 (18): 14602–6. PMID 11278268. doi:10.1074/jbc.C100103200. 
  6. ^ Régnier CH, Song HY, Gao X, Goeddel DV, Cao Z, Rothe M (July 1997). "Identification and characterization of an IkappaB kinase". Cell. 90 (2): 373–83. PMID 9244310. doi:10.1016/S0092-8674(00)80344-X. 
  7. ^ Xiao G, Sun SC (July 2000). "Negative regulation of the nuclear factor kappa B-inducing kinase by a cis-acting domain". J. Biol. Chem. 275 (28): 21081–5. PMID 10887201. doi:10.1074/jbc.M002552200. 
  8. ^ Ninomiya-Tsuji J, Kishimoto K, Hiyama A, Inoue J, Cao Z, Matsumoto K (March 1999). "The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway". Nature. 398 (6724): 252–6. PMID 10094049. doi:10.1038/18465. 
  9. ^ Woronicz JD, Gao X, Cao Z, Rothe M, Goeddel DV (October 1997). "IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK". Science. 278 (5339): 866–9. PMID 9346485. doi:10.1126/science.278.5339.866. 

Further reading[edit]